Personal care company Nu Skin (NYSE:NUS) will be reporting earnings tomorrow after the bell. Here’s what to expect.
Nu Skin beat analysts’ revenue expectations by 1.7% last quarter, reporting revenues of $439.1 million, down 12.2% year on year. It was a mixed quarter for the company, with an impressive beat of analysts’ EBITDA estimates but underwhelming earnings guidance for the full year.
Is Nu Skin a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Nu Skin’s revenue to decline 11.6% year on year to $441 million, a further deceleration from the 7.3% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.20 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Nu Skin has missed Wall Street’s revenue estimates five times over the last two years.
Looking at Nu Skin’s peers in the personal care segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Herbalife’s revenues decreased 3.2% year on year, missing analysts’ expectations by 1%, and Medifast reported a revenue decline of 40.6%, topping estimates by 1.5%. Herbalife traded up 10.2% following the results while Medifast was also up 8.6%.
Read our full analysis of Herbalife’s results here and Medifast’s results here.
Investors in the personal care segment have had steady hands going into earnings, with share prices up 1.2% on average over the last month. Nu Skin’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $9.58 (compared to the current share price of $6.43).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefitting from the rise of AI, available to you FREE via this link.
